Cargando…

Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism

A drug design for safer phenylbutazone was been explored by reactivity and docking studies involving single electron transfer mechanism, as well as toxicological predictions. Several approaches about its structural properties were performed through quantum chemistry calculations at the B3LYP level o...

Descripción completa

Detalles Bibliográficos
Autores principales: Borges, Rosivaldo S., Palheta, Ivanete C., Ota, Sirlene S. B., Morais, Roberto B., Barros, Valéria A., Ramos, Ryan S., Silva, Rai C., Costa, Josivan da S., Silva, Carlos H. T. P., Campos, Joaquín M., Santos, Cleydson B. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337259/
https://www.ncbi.nlm.nih.gov/pubmed/30609687
http://dx.doi.org/10.3390/molecules24010143
_version_ 1783388211845791744
author Borges, Rosivaldo S.
Palheta, Ivanete C.
Ota, Sirlene S. B.
Morais, Roberto B.
Barros, Valéria A.
Ramos, Ryan S.
Silva, Rai C.
Costa, Josivan da S.
Silva, Carlos H. T. P.
Campos, Joaquín M.
Santos, Cleydson B. R.
author_facet Borges, Rosivaldo S.
Palheta, Ivanete C.
Ota, Sirlene S. B.
Morais, Roberto B.
Barros, Valéria A.
Ramos, Ryan S.
Silva, Rai C.
Costa, Josivan da S.
Silva, Carlos H. T. P.
Campos, Joaquín M.
Santos, Cleydson B. R.
author_sort Borges, Rosivaldo S.
collection PubMed
description A drug design for safer phenylbutazone was been explored by reactivity and docking studies involving single electron transfer mechanism, as well as toxicological predictions. Several approaches about its structural properties were performed through quantum chemistry calculations at the B3LYP level of theory, together with the 6-31+G(d,p) basis sets. Molecular orbital and ionization potential were associated to electron donation capacity. The spin densities contribution showed a preferential hydroxylation at the para-positions of phenyl ring when compared to other positions. In addition, on electron abstractions the aromatic hydroxylation has more impact than alkyl hydroxylation. Docking studies indicate that six structures 1, 7, 8 and 13–15 have potential for inhibiting human as well as murine COX-2, due to regions showing similar intermolecular interactions to the observed for the control compounds (indomethacin and refecoxib). Toxicity can be related to aromatic hydroxylation. In accordance to our calculations, the derivatives here proposed are potentially more active as well safer than phenylbutazone and only structures 8 and 13–15 were the most promising. Such results can explain the biological properties of phenylbutazone and support the design of potentially safer candidates.
format Online
Article
Text
id pubmed-6337259
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63372592019-01-25 Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism Borges, Rosivaldo S. Palheta, Ivanete C. Ota, Sirlene S. B. Morais, Roberto B. Barros, Valéria A. Ramos, Ryan S. Silva, Rai C. Costa, Josivan da S. Silva, Carlos H. T. P. Campos, Joaquín M. Santos, Cleydson B. R. Molecules Article A drug design for safer phenylbutazone was been explored by reactivity and docking studies involving single electron transfer mechanism, as well as toxicological predictions. Several approaches about its structural properties were performed through quantum chemistry calculations at the B3LYP level of theory, together with the 6-31+G(d,p) basis sets. Molecular orbital and ionization potential were associated to electron donation capacity. The spin densities contribution showed a preferential hydroxylation at the para-positions of phenyl ring when compared to other positions. In addition, on electron abstractions the aromatic hydroxylation has more impact than alkyl hydroxylation. Docking studies indicate that six structures 1, 7, 8 and 13–15 have potential for inhibiting human as well as murine COX-2, due to regions showing similar intermolecular interactions to the observed for the control compounds (indomethacin and refecoxib). Toxicity can be related to aromatic hydroxylation. In accordance to our calculations, the derivatives here proposed are potentially more active as well safer than phenylbutazone and only structures 8 and 13–15 were the most promising. Such results can explain the biological properties of phenylbutazone and support the design of potentially safer candidates. MDPI 2019-01-01 /pmc/articles/PMC6337259/ /pubmed/30609687 http://dx.doi.org/10.3390/molecules24010143 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Borges, Rosivaldo S.
Palheta, Ivanete C.
Ota, Sirlene S. B.
Morais, Roberto B.
Barros, Valéria A.
Ramos, Ryan S.
Silva, Rai C.
Costa, Josivan da S.
Silva, Carlos H. T. P.
Campos, Joaquín M.
Santos, Cleydson B. R.
Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism
title Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism
title_full Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism
title_fullStr Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism
title_full_unstemmed Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism
title_short Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism
title_sort toward of safer phenylbutazone derivatives by exploration of toxicity mechanism
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337259/
https://www.ncbi.nlm.nih.gov/pubmed/30609687
http://dx.doi.org/10.3390/molecules24010143
work_keys_str_mv AT borgesrosivaldos towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism
AT palhetaivanetec towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism
AT otasirlenesb towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism
AT moraisrobertob towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism
AT barrosvaleriaa towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism
AT ramosryans towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism
AT silvaraic towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism
AT costajosivandas towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism
AT silvacarloshtp towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism
AT camposjoaquinm towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism
AT santoscleydsonbr towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism